Trademark Overview
On Monday, January 5, 2026, a trademark application was filed for CLAGALVY with the United States Patent and Trademark Office. The USPTO has given the CLAGALVY trademark a serial number of 99578166. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, January 5, 2026. This trademark is owned by AstraZeneca AB. The CLAGALVY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Vaccines; Antibodies for medical purposes